Rob C. van Wijk

446 total citations
24 papers, 326 citations indexed

About

Rob C. van Wijk is a scholar working on Infectious Diseases, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Rob C. van Wijk has authored 24 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Molecular Biology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Rob C. van Wijk's work include Tuberculosis Research and Epidemiology (7 papers), Computational Drug Discovery Methods (6 papers) and Receptor Mechanisms and Signaling (5 papers). Rob C. van Wijk is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Computational Drug Discovery Methods (6 papers) and Receptor Mechanisms and Signaling (5 papers). Rob C. van Wijk collaborates with scholars based in Sweden, Netherlands and United States. Rob C. van Wijk's co-authors include Piet H. van der Graaf, Herman P. Spaink, Elke H. J. Krekels, Thomas Hankemeier, Ulrika S. H. Simonsson, Vasudev Kantae, Amy C. Harms, Anita Ordas, Caryn M. Upton and Andreas H. Diacon and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Scientific Reports and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Rob C. van Wijk

24 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rob C. van Wijk Sweden	11	87	84	82	78	44	24	326
Miao Xu United States	11	171 2.0×	35 0.4×	158 1.9×	27 0.3×	45 1.0×	22	416
Marthe Bryant-Genevier United States	9	30 0.3×	19 0.2×	99 1.2×	57 0.7×	163 3.7×	11	354
Mir S. Adil United States	9	60 0.7×	32 0.4×	154 1.9×	32 0.4×	28 0.6×	25	372
Kajal Rawat India	9	173 2.0×	32 0.4×	146 1.8×	6 0.1×	18 0.4×	21	480
Nousheen Bibi Pakistan	11	50 0.6×	22 0.3×	178 2.2×	29 0.4×	29 0.7×	34	367
Changlong He China	10	182 2.1×	24 0.3×	94 1.1×	20 0.3×	38 0.9×	18	369
Krunoslav Nujić Croatia	9	61 0.7×	104 1.2×	96 1.2×	9 0.1×	83 1.9×	15	379
Kartikay Prasad India	14	165 1.9×	59 0.7×	210 2.6×	22 0.3×	23 0.5×	17	476
Lidan Hu China	11	30 0.3×	21 0.3×	250 3.0×	31 0.4×	56 1.3×	68	433

Countries citing papers authored by Rob C. van Wijk

Since Specialization

Citations

This map shows the geographic impact of Rob C. van Wijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob C. van Wijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob C. van Wijk more than expected).

Fields of papers citing papers by Rob C. van Wijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob C. van Wijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob C. van Wijk. The network helps show where Rob C. van Wijk may publish in the future.

Co-authorship network of co-authors of Rob C. van Wijk

This figure shows the co-authorship network connecting the top 25 collaborators of Rob C. van Wijk. A scholar is included among the top collaborators of Rob C. van Wijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob C. van Wijk. Rob C. van Wijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Strydom, Natasha, et al.. (2025). Selection and prioritization of candidate combination regimens for the treatment of tuberculosis. Science Translational Medicine. 17(784). eadi4000–eadi4000. 1 indexed citations

Wijk, Rob C. van, Natasha Strydom, Qianwen Wang, et al.. (2025). Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data. iScience. 28(3). 111932–111932. 1 indexed citations

Wijk, Rob C. van, et al.. (2024). Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic. Vaccines. 12(3). 329–329. 1 indexed citations

Wijk, Rob C. van, et al.. (2023). Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy. CPT Pharmacometrics & Systems Pharmacology. 12(7). 977–987. 4 indexed citations

Wijk, Rob C. van, et al.. (2023). Pharmacokinetic analysis across studies to drive knowledge‐integration: A tutorial on individual patient data meta‐analysis (IPDMA). CPT Pharmacometrics & Systems Pharmacology. 12(9). 1187–1200. 6 indexed citations

Strydom, Natasha, Qianwen Wang, Rob C. van Wijk, et al.. (2023). Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. European Respiratory Journal. 62(2). 2300165–2300165. 8 indexed citations

Wijk, Rob C. van, Ainhoa Lucía, Cyril Gaudin, et al.. (2023). Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium. iScience. 26(4). 106411–106411. 3 indexed citations

Wijk, Rob C. van, et al.. (2023). Seasonal influence on respiratory tract infection severity including COVID‐19 quantified through Markov Chain modeling. CPT Pharmacometrics & Systems Pharmacology. 12(9). 1250–1261. 3 indexed citations

Wijk, Rob C. van, et al.. (2023). Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development. Frontiers in Pharmacology. 14. 1150243–1150243. 2 indexed citations

10.

Wijk, Rob C. van, et al.. (2023). Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19. Scientific Reports. 13(1). 16292–16292. 4 indexed citations

11.

Jager, Veronique de, Nikhil Gupte, Sílvia Nunes, et al.. (2022). Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 205(10). 1228–1235. 23 indexed citations

12.

Upton, Caryn M., Rob C. van Wijk, Ulrika S. H. Simonsson, et al.. (2022). Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 48. 101414–101414. 55 indexed citations

13.

Wijk, Rob C. van, Dirk‐Jan van den Berg, Jeremy Liu, et al.. (2020). Anti‐tuberculosis effect of isoniazid scales accurately from zebrafish to humans. British Journal of Pharmacology. 177(24). 5518–5533. 11 indexed citations

14.

Wijk, Rob C. van, et al.. (2020). Model-Informed Drug Discovery and Development Strategy for the Rapid Development of Anti-Tuberculosis Drug Combinations. Applied Sciences. 10(7). 2376–2376. 13 indexed citations

15.

Wijk, Rob C. van, Astrid M. van der Sar, Elke H. J. Krekels, et al.. (2020). Quantification of Natural Growth of Two Strains of Mycobacterium Marinum for Translational Antituberculosis Drug Development. Clinical and Translational Science. 13(6). 1060–1064. 5 indexed citations

16.

Wijk, Rob C. van, Elke H. J. Krekels, Vasudev Kantae, et al.. (2019). Impact of post-hatching maturation on the pharmacokinetics of paracetamol in zebrafish larvae. Scientific Reports. 9(1). 2149–2149. 22 indexed citations

17.

Wijk, Rob C. van, Elke H. J. Krekels, Vasudev Kantae, et al.. (2019). Mechanistic and Quantitative Understanding of Pharmacokinetics in Zebrafish Larvae through Nanoscale Blood Sampling and Metabolite Modeling of Paracetamol. Journal of Pharmacology and Experimental Therapeutics. 371(1). 15–24. 24 indexed citations

18.

Wong, Yin Cheong, et al.. (2017). Development of a population pharmacokinetic model to predict brain distribution and dopamine D2 receptor occupancy of raclopride in non-anesthetized rat. European Journal of Pharmaceutical Sciences. 111. 514–525. 8 indexed citations

19.

Kantae, Vasudev, Elke H. J. Krekels, Anita Ordas, et al.. (2016). Pharmacokinetic Modeling of Paracetamol Uptake and Clearance in Zebrafish Larvae: Expanding the Allometric Scale in Vertebrates with Five Orders of Magnitude. Zebrafish. 13(6). 504–510. 53 indexed citations

20.

Wijk, Rob C. van, Elke H. J. Krekels, Thomas Hankemeier, Herman P. Spaink, & Piet H. van der Graaf. (2016). Systems pharmacology of hepatic metabolism in zebrafish larvae. Drug Discovery Today Disease Models. 22. 27–34. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact